Abstract
Digital breast tomosynthesis (DBT) is emerging as the new standard of care for breast cancer screening based on improved cancer detection coupled with reductions in recall compared to screening with digital mammography (DM) alone. However, many prior studies lack follow-up data to assess false negatives examinations. The purpose of this study is to assess if DBT is associated with improved screening outcomes based on follow-up data from tumor registries or pathology. Retrospective analysis of prospective cohort data from three research centers performing DBT screening in the PROSPR consortium from 2011 to 2014 was performed. Recall and biopsy rates were assessed from 198,881 women age 40–74 years undergoing screening (142,883 DM and 55,998 DBT examinations). Cancer, cancer detection, and false negative rates and positive predictive values were assessed on examinations with one year of follow-up. Logistic regression was used to compare DBT to DM adjusting for research center, age, prior breast imaging, and breast density. There was a reduction in recall with DBT compared to DM (8.7 vs. 10.4 %, p < 0.0001), with adjusted OR = 0.68 (95 % CI = 0.65–0.71). DBT demonstrated a statistically significant increase in cancer detection over DM (5.9 vs. 4.4/1000 screened, adjusted OR = 1.45, 95 % CI = 1.12–1.88), an improvement in PPV1 (6.4 % for DBT vs. 4.1 % for DM, adjusted OR = 2.02, 95 % CI = 1.54–2.65), and no significant difference in false negative rates for DBT compared to DM (0.46 vs. 0.60/1000 screened, p = 0.347). Our data support implementation of DBT screening based on increased cancer detection, reduced recall, and no difference in false negative screening examinations.
Similar content being viewed by others
Abbreviations
- BI-RADS:
-
Breast imaging-reporting and data system
- CI:
-
Confidence interval
- DBT:
-
Digital breast tomosynthesis
- D-BWH:
-
Dartmouth–Hitchcock health system in New Hampshire and Brigham and Women’s Hospital in Massachusetts
- DM:
-
Digital mammography
- GEE:
-
Generalized estimating equations
- NCI:
-
National Cancer Institute
- OR:
-
Odds ratio
- PPV1:
-
Positive predictive value
- PROSPR:
-
Population-based research optimizing screening through personalized regimens
- UPenn:
-
University of Pennsylvania
- US:
-
United States
- VT:
-
University of Vermont
References
Sechopoulos I (2013) A review of breast tomosynthesis. Part I. The image acquisition process. Med Phys 40(1):014301
Sechopoulos I (2013) A review of breast tomosynthesis. Part II., Image reconstruction, processing and analysis, and advanced applications. Med Phys 40(1):014302
Niklason LT, Christian BT, LE Niklason (1997) Digital tomosynthesis in breast imaging. Radiology 205.2:399–406
Skaane P, Bandos AI, Gullien R et al (2013) Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 267(1):47–56
Ciatto S, Houssami N, Bernardi D et al (2013) Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol 14(7):583–589
Rose SL, Tidwell AL, Bujnoch LJ et al (2013) Implementation of breast tomosynthesis in a routine screening practice: an observational study. AJR Am J Roentgenol 200(6):1401–1408
Friedewald SM, Rafferty EA, Rose SL et al (2014) Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 311(24):2499–2507
McCarthy AM, Kontos D, Synnestvedt M (2014) Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. J Natl Cancer Inst 106(11):dju316
Durand MA, Haas BM, Xiapan Y (2014) Early clinical experience with digital breast tomosynthesis for screening mammography. Radiology 274:1313–1319
Lourenco AP, Barry-Brooks M, Baird GL, Tuttle A, Mainiero MB (2014) Changes in recall type and patient treatment following implementation of screening digital breast tomosynthesis. Radiology 274:1403–1417
Haas BM, Kalr V, Geisel J et al (2013) Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 269(3):694–700
http://www.acr.org/News-Publications/News/News-Articles/2014/Economics/20141105-CMS-Establishes-Values-for-Breast-Tomosynthesis-in-2015-Final-Rule. accessed 9/30/2015
Onego T, Beaber EF, Sprague BL et al (2014) Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level. Cancer 120(19):2955–2964
D’Orsi CJ, Bassett LW, Berg WA, et al, (2003) BI-RADS: Mammography, 4th edition. In: D’Orsi CJ, Mendelson EB, Ikeda DM, et al: Breast imaging reporting and data system: ACR BI-RADS—breast Imaging Atlas. Reston, VA: American College of Radiology;
http://breastscreening.cancer.gov/statistics/benchmarks/screening/ Accessed 9/30/2015
Houssami N, Macaskill P, Bernardi D et al (2014) Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading—evidence to guide future screening strategies. Eur J Cancer 50(10):1799–1807
Houssami N, Abraham LA, Kerlikowske K (2013) Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev 22:946–961
McDonald ES, Oustimov A, Weinstein SP, Synnestvedt M, Schnall M, Conant EF (2016) Effectiveness of digital breast tomosynthesis compared with digital mammography: Outcomes analysis from 3 years of breast cancer screening. JAMA Onc. doi:10.001/jamaoncol.2015.5536
Acknowledgments
The authors thank the participating PROSPR Research Centers for the data they have provided for this study. A list of the PROSPR investigators and contributing research staff are provided at: http://healthcaredelivery.cancer.gov/prospr/.
Author contributions
Dr. Conant had full access to all the data in the study and takes responsibility for the integrity.
Funding
This work was supported by the National Cancer Institute (NCI)-funded Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium (Grant numbers U01CA163304 to M.T., W.B.; U54CA163303 and P01 CA154292 to D.L.W., B.S., S.H.; U54CA163307 to A.N.A.T., T.O., J.H.; U54CA163313 to E.F.C., K.A., M.S.)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Author E.F.C. is a consultant and has been a lecturer for Hologic, Inc., Bedford MA and Siemen’s Healthcare. Author S.P.P. has been renumerated for participating as a reader for Biomedical Systems, St. Louis, MO. Author S.D.H. holds stock in Hologic, Inc. Bedford, MA. Author K.A. is a consultant to GlaxoSmithKline, Philadelphia, PA.
Additional information
On behalf of the PROSPR consortium.
Rights and permissions
About this article
Cite this article
Conant, E.F., Beaber, E.F., Sprague, B.L. et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat 156, 109–116 (2016). https://doi.org/10.1007/s10549-016-3695-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-016-3695-1